Laboratory of Lymphocyte Signaling and Oncoproteome

TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state

Herling, M Patel, KA Khalili, J Schlette, E Kobayashi, R Medeiros, LJ Jones, D
Leukemia 20, 2February, 2006Pages: 280-5doi: 10.1038/sj.leu.2404017ISSN: 1476-5551https://www.nature.com/articles/2404017/

Full text

News

Future therapies in T-PLL and T-LGL

Future therapies in T-PLL and T-LGL

June 7, 2021

New perspective on future targeted therapy approaches published.

New article accepted for publication

New article accepted for publication

August 30, 2020

Our work on T-PLL cells resembling the phenotype of activated memory-type effector T-cells has been accepted in Blood

Alkylating deacetylase inhibitor tinostamustine in T-PLL

March 11, 2020

New letter evaluating the effects of EDO-S101/tinostamustine published in Leukemia.

Advances and Perspectives in the Treatment of T-PLL

Advances and Perspectives in the Treatment of T-PLL

February 25, 2020

New review on current and future strategies in treating T-PLL published in Current Hematologic Malignancy Reports